Form 8-K - Current report:
SEC Accession No. 0000950170-24-117462
Filing Date
2024-10-25
Accepted
2024-10-25 17:00:08
Documents
11
Period of Report
2024-10-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K tbio-20241021.htm   iXBRL 8-K 40024
  Complete submission text file 0000950170-24-117462.txt   161153

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tbio-20241021.xsd EX-101.SCH 26958
14 EXTRACTED XBRL INSTANCE DOCUMENT tbio-20241021_htm.xml XML 5101
Mailing Address 10431 WATERIDGE CIRCLE SUITE 150 SAN DIEGO CA 92121
Business Address 10431 WATERIDGE CIRCLE SUITE 150 SAN DIEGO CA 92121 858-228-4115
Telesis Bio Inc. (Filer) CIK: 0001850079 (see all company filings)

EIN.: 451216839 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40497 | Film No.: 241397717
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)